stockrowCVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +7.26%
- EPS
- +187.7%
- Free cash flow
- +338.3%
- Total debt
- −7.64%
Quarter to June 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) Shares outstanding
CVS Health Corporation's shares outstanding at the end of fiscal 2025 was $1.3B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $1.3B. Over the past ten years it has ranged from $1.0B (fiscal 2017) to $1.3B (fiscal 2021); the current reading is higher than 55% of that period. CVS Health Corporation ranks 1st of 12 Healthcare Plans companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $1.3B | 0.71% |
| FY2024 | $1.3B | (2.17%) |
| FY2023 | $1.3B | (2.49%) |
| FY2022 | $1.3B | (0.45%) |
| FY2021 | $1.3B | 1.14% |
| FY2020 | $1.3B | 0.69% |
| FY2019 | $1.3B | 25.00% |
| FY2018 | $1.0B | 1.95% |
| FY2017 | $1.0B | (5.10%) |
| FY2016 | $1.1B | (4.17%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $1.3B | 0.63% |
| Mar 2026 | $1.3B | 0.63% |
| Dec 2025 | $1.3B | 0.16% |
| Sep 2025 | $1.3B | (0.08%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CVS CVS Health Corporation | $1.3B |
| UNH UnitedHealth Group Incorporated compare | $902.0M |
| CLOV Clover Health Investments, Corp. compare | $545.4M |
| CNC Centene Corporation compare | $494.1M |
| OSCR Oscar Health, Inc. compare | $333.4M |
| CI Cigna Group compare | $264.0M |
| ELV Elevance Health, Inc. compare | $217.6M |
| HUM Humana Inc. compare | $121.1M |
| MOH Molina Healthcare, Inc compare | $51.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement